Proof‐of‐principle demonstration of endogenous circadian system and circadian misalignment effects on human oral microbiota

2021 ◽  
Vol 36 (1) ◽  
Author(s):  
Sarah L. Chellappa ◽  
Phillip A. Engen ◽  
Ankur Naqib ◽  
Jingyi Qian ◽  
Nina Vujovic ◽  
...  
2018 ◽  
Vol 43 (8) ◽  
pp. 1644-1649 ◽  
Author(s):  
Jingyi Qian ◽  
Christopher J. Morris ◽  
Rosanna Caputo ◽  
Marta Garaulet ◽  
Frank A. J. L. Scheer

SLEEP ◽  
2019 ◽  
Vol 42 (Supplement_1) ◽  
pp. A20-A21
Author(s):  
Sarah L Chellappa ◽  
Phillip A Engen ◽  
Ankur Naqib ◽  
Nishath Rahman ◽  
Stefan J Green ◽  
...  

2018 ◽  
Vol 20 (10) ◽  
pp. 2481-2485 ◽  
Author(s):  
Jingyi Qian ◽  
Chiara Dalla Man ◽  
Christopher J. Morris ◽  
Claudio Cobelli ◽  
Frank A. J. L. Scheer

2019 ◽  
Vol 116 (47) ◽  
pp. 23806-23812 ◽  
Author(s):  
Jingyi Qian ◽  
Christopher J. Morris ◽  
Rosanna Caputo ◽  
Wei Wang ◽  
Marta Garaulet ◽  
...  

Shift work causes circadian misalignment and is a risk factor for obesity. While some characteristics of the human circadian system and energy metabolism differ between males and females, little is known about whether sex modulates circadian misalignment effects on energy homeostasis. Here we show—using a randomized cross-over design with two 8-d laboratory protocols in 14 young healthy adults (6 females)—that circadian misalignment has sex-specific influences on energy homeostasis independent of behavioral/environmental factors. First, circadian misalignment affected 24-h average levels of the satiety hormone leptin sex-dependently (P < 0.0001), with a ∼7% decrease in females (P < 0.05) and an ∼11% increase in males (P < 0.0001). Consistently, circadian misalignment also increased the hunger hormone ghrelin by ∼8% during wake periods in females (P < 0.05) without significant effect in males. Females reported reduced fullness, consistent with their appetite hormone changes. However, males reported a rise in cravings for energy-dense and savory foods not consistent with their homeostatic hormonal changes, suggesting involvement of hedonic appetite pathways in males. Moreover, there were significant sex-dependent effects of circadian misalignment on respiratory quotient (P < 0.01), with significantly reduced values (P < 0.01) in females when misaligned, and again no significant effects in males, without sex-dependent effects on energy expenditure. Changes in sleep, thermoregulation, behavioral activity, lipids, and catecholamine levels were also assessed. These findings demonstrate that sex modulates the effects of circadian misalignment on energy metabolism, indicating possible sex-specific mechanisms and countermeasures for obesity in male and female shift workers.


2015 ◽  
Vol 112 (17) ◽  
pp. E2225-E2234 ◽  
Author(s):  
Christopher J. Morris ◽  
Jessica N. Yang ◽  
Joanna I. Garcia ◽  
Samantha Myers ◽  
Isadora Bozzi ◽  
...  

Glucose tolerance is lower in the evening and at night than in the morning. However, the relative contribution of the circadian system vs. the behavioral cycle (including the sleep/wake and fasting/feeding cycles) is unclear. Furthermore, although shift work is a diabetes risk factor, the separate impact on glucose tolerance of the behavioral cycle, circadian phase, and circadian disruption (i.e., misalignment between the central circadian pacemaker and the behavioral cycle) has not been systematically studied. Here we show—by using two 8-d laboratory protocols—in healthy adults that the circadian system and circadian misalignment have distinct influences on glucose tolerance, both separate from the behavioral cycle. First, postprandial glucose was 17% higher (i.e., lower glucose tolerance) in the biological evening (8:00 PM) than morning (8:00 AM; i.e., a circadian phase effect), independent of the behavioral cycle effect. Second, circadian misalignment itself (12-h behavioral cycle inversion) increased postprandial glucose by 6%. Third, these variations in glucose tolerance appeared to be explained, at least in part, by different mechanisms: during the biological evening by decreased pancreatic β-cell function (27% lower early-phase insulin) and during circadian misalignment presumably by decreased insulin sensitivity (elevated postprandial glucose despite 14% higher late-phase insulin) without change in early-phase insulin. We explored possible contributing factors, including changes in polysomnographic sleep and 24-h hormonal profiles. We demonstrate that the circadian system importantly contributes to the reduced glucose tolerance observed in the evening compared with the morning. Separately, circadian misalignment reduces glucose tolerance, providing a mechanism to help explain the increased diabetes risk in shift workers.


2016 ◽  
Vol 101 (3) ◽  
pp. 1066-1074 ◽  
Author(s):  
Christopher J. Morris ◽  
Taylor E. Purvis ◽  
Joseph Mistretta ◽  
Frank A. J. L. Scheer

Abstract Context: Shift work is a risk factor for diabetes. The separate effects of the endogenous circadian system and circadian misalignment (ie, misalignment between the central circadian pacemaker and 24-hour environmental/behavioral rhythms such as the light/dark and feeding/fasting cycles) on glucose tolerance in shift workers are unknown. Objective: The objective of the study was to test the hypothesis that the endogenous circadian system and circadian misalignment separately affect glucose tolerance in shift workers, both independently from behavioral cycle effects. Design: A randomized, crossover study with two 3-day laboratory visits. Setting: Center for Clinical Investigation at Brigham and Women's Hospital. Patients: Healthy chronic shift workers. Intervention: The intervention included simulated night work comprised of 12-hour inverted behavioral and environmental cycles (circadian misalignment) or simulated day work (circadian alignment). Main Outcome Measures: Postprandial glucose and insulin responses to identical meals given at 8:00 am and 8:00 pm in both protocols. Results: Postprandial glucose was 6.5% higher at 8:00 pm than 8:00 am (circadian phase effect), independent of behavioral effects (P = .0041). Circadian misalignment increased postprandial glucose by 5.6%, independent of behavioral and circadian effects (P = .0042). These variations in glucose tolerance appeared to be explained, at least in part, by different insulin mechanisms: during the biological evening by decreased pancreatic β-cell function (18% lower early and late phase insulin; both P ≤ .011) and during circadian misalignment presumably by decreased insulin sensitivity (elevated postprandial glucose despite 10% higher late phase insulin; P = .015) without change in early-phase insulin (P = .38). Conclusions: Internal circadian time affects glucose tolerance in shift workers. Separately, circadian misalignment reduces glucose tolerance in shift workers, providing a mechanism to help explain the increased diabetes risk in shift workers.


2005 ◽  
Vol 24 (01) ◽  
pp. 36-40
Author(s):  
A. Storch ◽  
J. Schwarz

ZusammenfassungDer Ersatz dopaminerger Neurone bei Patienten mit Morbus Parkinson bleibt eine attraktive Behandlungsstrategie. Die Implantation von embryonalem Mittelhirngewebe war die erste Therapie, die nicht nur den »Proof-of-Principle« in Tierversuchen lieferte, sondern auch Eingang in klinische Applikationen fand. 1987 wurde zunächst eine Reihe von kleinen offenen Studien mit sorgfältiger Patientenselektion gestartet, die sehr ermutigende Ergebnisse bei zumindest einem Teil der Patienten erbrachten. In den vergangenen Jahren wurden in den USA zwei doppelblinde, kontrollierte Studien abgeschlossen, deren Resultate eher enttäuschend blieben, da die primären Endpunkte (Besserung der Parkinson-Symptomatik im Off) keine signifikanten Unterschiede zeigten. Zudem wurden in beiden Studien 12 Stunden nach L-Dopa-Einnahme Dyskinesien beobachtet. Die Ursachen dieser unterschiedlichen Ergebnisse könnten in der Variabilität des Gewebes, relevanten Immunreaktionen und ungleichmäßiger Dopaminausschüttung im Striatum liegen. Zudem legen die ethischen Probleme bei der Gewinnung des Gewebes die Notwendigkeit anderer, besser standardisierter Gewebe nahe. Derzeit scheint es möglich, dass alternativ sowohl aus embryonalen als auch neuralen Stammzellen, vielleicht sogar aus körpereigenen mesenchymalen Stammzellen dopaminerge Neurone generiert werden könnten. Diese Zellen können über einen langen Zeitraum expandiert, ausreichend standardisiert und charakterisiert werden.


2018 ◽  
Author(s):  
Zhanyu Li ◽  
Mengru Zhang ◽  
Yu Zhang ◽  
Shuang Liu ◽  
Jinbo Zhao ◽  
...  

Deployment of organoboron in lieu of the strongly basic <br>organometallic reagents as carbon source in Cu-catalyzed <br>cyclopropene carbometallation opens unprecedented three-<br>component reactivity for stereoselective synthesis of poly-substituted cyclopropanes. A proof-of-principle demonstration of this novel carbometallation strategy is presented herein for a highly convergent access to poly-substituted aminocyclopropane framework via <br>carboamination. Preliminary results on asymmetric desymmetrization with commercial bisphosphine ligands attained high levels of enantioselection, offering a straightforward access to enantioenriched aminocyclopropanes bearing all-three chiral centers, including an all-carbon quaternary center. This strategy may underpin a host of novel synthetic protocols for poly-substituted cyclopropanes. <br>


2019 ◽  
Author(s):  
Michael Olp ◽  
Daniel Sprague ◽  
Stefan Kathman ◽  
Ziyang Xu ◽  
Alexandar Statsyuk ◽  
...  

<p>Brd4, a member of the bromodomain and extraterminal domain (BET) family, has emerged as a promising epigenetic target in cancer and inflammatory disorders. All reported BET family ligands bind within the bromodomain acetyl-lysine binding sites and competitively inhibit BET protein interaction with acetylated chromatin. Alternative chemical probes that act orthogonally to the highly-conserved acetyl-lysine binding sites may exhibit selectivity within the BET family and avoid recently reported toxicity in clinical trials of BET bromodomain inhibitors. Here, we report the first identification of a ligandable site on a bromodomain outside the acetyl-lysine binding site. Inspired by our computational prediction of hotspots adjacent to non-homologous cysteine residues within the <i>C</i>-terminal Brd4 bromodomain (Brd4-BD2), we performed a mid-throughput mass spectrometry screen to identify cysteine-reactive fragments that covalently and selectively modify Brd4. Subsequent mass spectrometry, NMR and computational docking analyses of electrophilic fragment hits revealed a novel ligandable site near Cys356 that is unique to Brd4 among all human bromodomains. This site is orthogonal to the Brd4-BD2 acetyl-lysine binding site as Cys356 modification did not impact binding of the pan-BET bromodomain inhibitor JQ1 in fluorescence polarization assays. Finally, we tethered covalent fragments to JQ1 and performed NanoBRET assays to provide proof of principle that this orthogonal site can be covalently targeted in intact human cells. Overall, we demonstrate the potential of targeting sites orthogonal to bromodomain acetyl-lysine binding sites to develop bivalent and covalent inhibitors that displace Brd4 from chromatin.</p>


Sign in / Sign up

Export Citation Format

Share Document